CORC

在结果中检索

CORC

浏览/检索结果: 共204条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Efficacy and Safety of Gefitinib as Third-line Treatment in NSCLC Patients With Activating EGFR Mutations Treated With First-line Gefitinib Followed by Second-line Chemotherapy A Single-Arm, Prospective, Multicenter Phase II Study (RE-CHALLENGE, 期刊论文
2019, 卷号: 42, 期号: 5, 页码: 432-439
作者:  Song, Yong;  Wu, Yi-Long;  Cao, Le-Jie;  Chen, Jian-Hua;  Ma, Zhi-Yong
收藏  |  浏览/下载：31/0  |  提交时间：2020/01/03
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer 会议论文
CANCER RESEARCH, 2019-02-01
作者:  Zhu, A.;  Yuan, P.;  Wang, J.;  Fan, Y.;  Luo, Y.
收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03
Phase II study of antiangiogenic tyrosine kinase inhibitor apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative advanced breast cancer 期刊论文
2019, 卷号: 79, 期号: 4
作者:  Zhu, A.;  Yuan, P.;  Wang, J.;  Fan, Y.;  Luo, Y.
收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03
Pyrotinib or Lapatinib Combined With Capecitabine in HER2-Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study 期刊论文
2019, 卷号: 37, 期号: 29, 页码: 2610-2619
作者:  Ma Fei;  Ouyang Quchang;  Li Wei;  Jiang Zefei;  Tong Zhongsheng
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Efficacy, immunogenicity and safety of the AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years: End-of-study results from a phase II/III, randomised, controlled trial 期刊论文
2019
作者:  Zhu Feng-Cai;  Hu Shang-Ying;  Hong Ying;  Hu Yue-Mei;  Zhang Xun
收藏  |  浏览/下载：24/0  |  提交时间：2020/01/03
Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer 期刊论文
2019, 卷号: 68, 期号: 1, 页码: 121-130
作者:  Zhang, Wen;  Lu, Xu;  Cui, Peilin;  Piao, Chunmei;  Xiao, Man
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
A Phase II Trial of Concurrent Temozolomide and Hypofractionated Stereotactic Radiotherapy for Complex Brain Metastases 期刊论文
2019, 卷号: 24, 期号: 9, 页码: e914-e920
作者:  Bi Nan;  Ma Yuchao;  Xiao Jianping;  Zhang Hongmei;  Xu Yingjie
收藏  |  浏览/下载：42/0  |  提交时间：2020/01/03
Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial 期刊论文
2019, 卷号: 25, 期号: 12, 页码: 3486-3494
作者:  Xu, Jianming;  Li, Jie;  Bai, Chunmei;  Xu, Nong;  Zhou, Zhiwei
收藏  |  浏览/下载：23/0  |  提交时间：2020/01/03
HELPER study: A phase II trial of continuous infusion of endostar combined with concurrent etoposide plus cisplatin and radiotherapy for treatment of unresectable stage III non-small-cell lung cancer 期刊论文
2019, 卷号: 131, 页码: 27-34
作者:  Zhai, Yirui;  Ma, Honglian;  Hui, Zhouguang;  Zhao, Lujun;  Li, Dongming
收藏  |  浏览/下载：32/0  |  提交时间：2020/01/03
Anlotinib Versus Sunitinib as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial 期刊论文
2019, 卷号: 24, 期号: 8, 页码: E702-E708
作者:  Zhou, Ai-Ping;  Bai, Yuxian;  Song, Yan;  Luo, Hong;  Ren, Xiu-Bao
收藏  |  浏览/下载：18/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace